| Direct Activation of the Olfactory Cyclic Nucleotide–Gated Channel through Modification of Sulfhydryl Groups by NO Compounds Neuron, Volume 16, Issue 2, 1 February 1996, Pages 377-385 Marie-Christine Broillet and Stuart Firestein Summary The activation of a cyclic nucleotide–gated channel is the final step in sensory transduction in olfaction. Normally, this channel is opened by the intracellular cyclic nucleotide second messenger cAMP or cGMP. However, in single channel recordings we found that donors of nitric oxide, a putative intercellular messenger, could directly activate the native olfactory neuron channel. Its action was independent of the presence of the normal ligand and did not involve the cyclic nucleotide binding site, suggesting an alternate site on the molecule that is critical in channel gating. The biochemical pathway appears to utilize nitric oxide in one of its alternate redox states, the nitrosonium ion, transnitrosylating a free sulfhydryl group belonging to a cysteine residue tentatively identified as being in the region linking the S6 transmembrane domain to the ligand binding domain. Summary | Full Text | PDF (130 kb) |
| Redox Modulation of T-Type Calcium Channels in Rat Peripheral Nociceptors Neuron, Volume 31, Issue 1, 19 July 2001, Pages 75-85 Slobodan M. Todorovic, Vesna Jevtovic-Todorovic, Adam Meyenburg, Steven Mennerick, Edward Perez-Reyes, Carmelo Romano, John W. Olney and Charles F. Zorumski Summary Although T-type calcium channels were first described in sensory neurons, their function in sensory processing remains unclear. In isolated rat sensory neurons, we show that redox agents modulate T currents but not other voltage- and ligand-gated channels thought to mediate pain sensitivity. Similarly, redox agents modulate currents through Ca3.2 recombinant channels. When injected into peripheral receptive fields, reducing agents, including the endogenous amino acid L-cysteine, induce thermal hyperalgesia. This hyperalgesia is blocked by the oxidizing agent 5,5′-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T channel antagonist mibefradil. DTNB alone and in combination with mibefradil induces thermal analgesia. Likewise, L-cysteine induces mechanical DTNB-sensitive hyperalgesia in peripheral receptive fields. These data strongly suggest a role for T channels in peripheral nociception. Redox sites on T channels in peripheral nociceptors could be important targets for agents that modify pain perception. Summary | Full Text | PDF (249 kb) |
| Tight Steric Closure at the Intracellular Activation Gate of a Voltage-Gated K Channel Neuron, Volume 32, Issue 4, 20 November 2001, Pages 649-656 Donato del Camino and Gary Yellen Summary In voltage-gated K channels (Kv), an intracellular gate regulates access from the cytoplasm to the pore by organic channel blockers and by chemical modifiers. But is ion flow itself controlled instead by constriction of the narrow selectivity filter near the extracellular surface? We find that the intracellular gate of Kv channels is capable of regulating access even by the small cations Cd and Ag. It can also exclude small neutral or negatively charged molecules, indicating that the gate operates by steric exclusion rather than electrostatically. Just intracellular to the gated region, channel closure does not restrict access even to very large reagents. Either these Kv channels have a broader inner entrance than seen in the KcsA crystal, even in the closed state, or the region is highly flexible (but nevertheless remains very securely closed nearby). Summary | Full Text | PDF (303 kb) |
Copyright © 1999 The Biophysical Society. All rights reserved.
Biophysical Journal, Volume 77, Issue 6, 3010-3022, 1 December 1999
doi:10.1016/S0006-3495(99)77132-8
Channels, Receptors, and Transporters
Claudia S. Haarmann*, Rainer H.A. Fink# and Angela F. Dulhunty*,
, 
* Muscle Research Group, John Curtin School of Medical Research, Canberra, ACT 2601, Australia
# Second Institute of Physiology, University of Heidelberg, Heidelberg D69120, Germany
Address reprint requests to Dr. A. F. Dulhunty, Division of Biochemistry and Molecular Biolgy, John Curtin School of Medical Research, Australian National University, P.O. Box 334, Canberra, ACT 2601, Australia. Tel.: 61-2-6249-4491; Fax: 61-2-6249-4761.Contraction of striated muscle depends on Ca2+ release from the sarcoplasmic reticulum (SR), through ryanodine receptor (RyR) calcium release channels. Oxidants are important ligands in the physiological activity of RyRs and act by oxidation of free sulfhydryl (SH) groups, because their effects are prevented by sulfhydryl reducing agents (Boraso and Williams, 1994,Favero et al,Abramson et al). Oxidants activate and can inhibit RyRs (Holmberg et al,Holmberg and Williams, 1992,Boraso and Williams, 1994,Favero et al,Stoyanovsky et al). Oxidation-induced activation proceeds under in vivo conditions, in the presence of glutathione (GSH) (Koshita et al), and is enhanced during ischemia or reperfusion, in which oxygen free radicals increase and the ratio of GSH:GSSG falls (Sies et al,Curello et al).
Reagents that react specifically with free SH groups are used as model compounds to look at the effects of oxidation and the importance of cysteine residues in RyR channel function. Reactive disulfides 4,4′- or 2,2′-dithiodipyridine (4,4′-DTDP or 2,2′-DTDP) activate and then block cardiac RyRs when applied to the cytoplasmic (cis) side of the channels (Eager et al,Eager and Dulhunty, 1998). Skeletal RyRs have also been reported to be activated, but not inhibited, by cis 4,4′- or 2,2′-DTDP and by GSSH (Nagura et al,Marengo et al) and to be inhibited by the reducing agents GSH, dithiothreitol (DTT), or β-mercaptoethanol (BME). The domain of the RyR on which oxidants act is not clear. Both lipid-soluble and water-soluble reagents can partition into the membrane, to a greater or lesser extent, depending on their pKa values and could react with -SH groups on either the side to which they are added or in the transmembrane parts of the RyR protein. It is unlikely that reagents would act rapidly on the opposite side of the bilayer, because reagent crossing the bilayer would be diluted in the large volume of the opposite solution and would take a long time to reach activating concentrations. Water-soluble oxidants appear to react with SH groups only in the cytoplasmic or transmembrane domains of the mammalian RyRs. Methanethiosulfonate derivatives block skeletal muscle RyRs only from the cis side (Quinn and Ehrlich, 1997). Some residues (-aSH and -iSH) responsible for activation or inhibition of cardiac RyRs are accessible to thimerosal from either side of the bilayer and are located in the transmembrane domain, while other activating (-a*SH) residues are confined to the cytoplasmic domain (Eager and Dulhunty, 1999). There have been no similar reports of the long-term effects of thiol-specific oxidizing agents added to the luminal or cytoplasmic sides of mammalian skeletal RyR channels.
The present study examines the effects on single skeletal RyRs of long exposure to 2–10mM concentrations of the thiol-specific 4,4′-DTDP or 5,5′-dithiobis-(2Nitrobenzoic acid) (DTNB) or DTT. The experiments tested the hypothesis that, as in cardiac RyRs (Eager and Dulhunty, 1999), three classes of -SH (-aSH and -iSH, within the transmembrane domain, or -a*SH in the cytoplasmic domain) are available in skeletal RyRs for oxidation by specific sulfhydryl reagents. It was possible that the same thiols could be oxidized in cardiac and skeletal RyRs, because 71 of >80 cysteine residues are conserved between the two isoforms (Otsu et al). The experiments tested an additional hypothesis that the Arg615-to-Cys615 substitution in RyRMH from pigs susceptible to malignant hyperthermia (MH) provides an additional -SH group for oxidation. MH is an inherited skeletal muscle disorder, characterized by increased Ca2+ release from SR (Ohta et al,Carrier et al,Mickelson and Louis, 1996) and reduced inhibition of RyRs by Ca2+ (Fill et al,Shomer et al) or Mg2+ (Laver et al).
Novel findings are 1) that the water-soluble DTNB (in either cis or trans solutions) and the lipid-soluble 4,4′-DTDP (in the cis solution) activate skeletal RyRs in a similar way; 2) 4,4′-DTDP added to the cis solution, but not DTNB (cis or trans), inhibits skeletal RyRs after >5min; 3) in the absence of an oxidizing reagent, 10mM DTT activates skeletal RyRs from the cis or trans solution; 4) “control-like” channel activity is maintained when 1mM DTNB and 10mM DTT are present together on either the same or opposite sides of the bilayer; and 5) effects of oxidation and reduction are the same in normal RyRs and RyRMH. Our conclusions are that 1) -aSH is located in the skeletal RyR transmembrane domain, as in cardiac RyRs; 2) -a*SH, in cardiac RyRs, is not available for oxidation in skeletal RyRs; 3) a modified thiol in the transmembrane domain (-abS-R, where R is either a protein S if the modified thiol is a disulfide, or an N if the modified group is nitrosylated; Xu et al) normally suppresses skeletal RyR activity; and 4) the Arg615-to-Cys615 substitution in MH does not provide an additional SH group for oxidation by thiol-specific reagents.
The methods for genetic testing, muscle dissection, caffeine-halothane contracture testing, preparation of SR vesicles, and single-channel recording have been described previously (Otsu et al,Owen et al,Laver et al). Muscle and blood samples were obtained from three homozygous normal pigs (one Belgium Landrace and two Landrace) and three homozygous MH pigs (two Belgium Landrace and one Landrace) aged ∼4 months. Each animal was genetically tested for a normal or MH RyR allele (containing either Arg615 or Cis615). The SR preparations were from the same animals as those used in Laver et al. The description of anesthetic techniques, muscle dissection, and halothane/caffeine contracture tests are given by Laver et al. All fiber bundles from the three homozygous normal animals failed to respond to halothane or 2mM caffeine, while all fiber bundles from the three homozygous MH animals developed tension in response to both drugs.
The preparation of crude SR vesicles was based on the methods of Meissner, 1984 and Ma et al. The freshly dissected back and leg muscle was washed in cold phosphate-buffered saline containing 2mM EGTA (pH 7.0), trimmed of fat and connective tissue, cubed, and either frozen in liquid N2 and stored at −70°C or freshly processed. The fresh or thawed muscle cubes were suspended in (mM) 5 Tris maleate, 100 NaCl, 2 EDTA, 0.1 EGTA (pH 6.8) (5 ml/g of tissue). The muscle was homogenized in a Waring blender in four 15-s high-speed bursts. The homogenate was centrifuged at 2600×g for 30min, and the supernatant ws filtered through cotton gauze and centrifuged at 10,000×g for 30min. The pellet (P2) was collected, and the supernatant was centrifuged again at 35,000×g and the pellet (P3) collected. Pellets P2 and P3 were resuspended in (mM) 5 Tris-2-(N-morpholino)ethanesulfonic acid (Tris-MES), 300 sucrose, 100 KCl, 2 DTT (pH 6.8). Aliquots of the suspensions were frozen in liquid nitrogen and stored at −70°C. All buffers contained the protease inhibitors phenylmethylsulfonyl fluoride (0.7mM), leupeptin (1μg/ml), pepstatin A (1μM), and benzamidine (1mM).
The lipid bilayer and single-channel recording technique are described by Ahern et al and Laver et al. (1995). Bilayers were formed from phosphatidylethanolamine, phosphatidylserine, and phosphatidylcholine (5:3:2 w/w) (Avanti Polar Lipids, Alabaster, AL) across an aperture with a diameter of 200–250μm in the wall of a 1.0-ml Delrin cup (Cadillac Plastics, Australia). TC vesicles (final concentration 10μg/ml) were added to the cis chamber and stirred until vesicle incorporation was observed. The cytoplasmic side of channels incorporated into the bilayer faced the cis solution. The bilayer potential was controlled and single-channel activity was recorded with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA). For experimental purposes, the cis chamber was held at ground and the voltage of the trans chamber was controlled. Bilayer potential is expressed in the conventional way as Vcis−Vtrans (i.e., Vcytoplasm−Vlumen).
Bilayers were formed and vesicles incorporated into the bilayer, using cis and trans solutions containing (mM) 230 Cs methanesulfonate (CsMS), 20 CsCl, 0.1 CaCl2, and 10 N-tris[hyroxymethyl]methyl-2-aminoethanesulfonic acid (TES) (pH 7.4 adjusted with CsOH). The cis solution also contained 500mM mannitol to aid SR vesicle fusion and RyR incorporation into the bilayer.
Channel activity was recorded at −40mV. In general activity was recorded for a 2-min control period before and 1min after 0.5-s voltage pulses to +40mV. Drugs were then added to either the cis or trans chamber with a ∼10-s stirring period, and then activity was recorded for several minutes. Voltage pulses to +40mV were occasionally applied to the bilayer after drug addition to determine whether channels could be activated by the change in bilayer potential. Because RyR channel activity can increase immediately after a voltage pulse (Zahradnikova and Meszaros, 1998,Laver and Lamb, 1998), the first 30s after each voltage pulse was excluded from analysis.
Channel activity was filtered at 1kHz (10-pole low-pass Bessel, −3dB) and digitized at 2kHz. Analysis of single-channel records (using Channel 2, written by P. W. Gage and M. Smith) yielded channel open probability (Po), frequency of events (Fo), open times, closed times, and mean open or closed times (To or Tc), as well as mean current (I′). The open discriminator was set at ∼25% of the maximum current, and the closed discriminator at 50% of the open discriminator, so that openings to both subconductance and maximum conductance levels were included in the analysis. Single-channel parameters were measured during the 30s, showing maximum I′ during the control period and then the period of maximum I′ after the addition of drugs. Dwell-time distributions were plotted as the frequency of openings in logged bins (Sigworth and Sine, 1987) to display the large range of open times seen in control recordings and after the addition of oxidizing reagents. The fit of a multiple exponential function to the data was assessed using a least-squares fit.
Average data are given as mean±SEM. The significance of the difference between control and test values was evaluated with a Student's t-test, either one or two sided and for independent or paired data, as appropriate. Differences were considered to be significant when p≤0.05.
RyRs from homozygous normal pig muscle were activated by addition of the hydrophilic DTNB (1mM) to either the cis or trans chamber. Control RyR activity was characterized by brief openings to the maximum conductance and to lower conductance levels (Figure 1ABAB and Figure 2ABAB). Longer openings appeared with DTNB (Figure 1AB and Figure 2AB). Channel activity increased with a delay of ∼1min after DTNB was added to the cis chamber in 13 of 14 channels, with a delay of ∼3min after trans DTNB was added to 10 of 11 RyRs. Average mean current (I′) increased from a control value of −1.43±0.12 pA to −3.91±0.19 pA (n=10) or from −2.73±0.38 pA to −5.81±0.64 pA (n=6). When the average ratio of mean current before and after addition of the drugs for individual channels was determined, there was an approximately fivefold increase with cis DTNB and an approximately threefold increase with trans DTNB (Table 1). Note that the delay was assessed by eye from channel records. The numbers of channels for I′ in Table 1 are fewer than the number for the delay because I′ was measured using Channel2 analysis of low-noise recordings only.
| Table 1 Average effect of drugs on mean current, I′, in normal RyRs (normal) and RyRMH (MH) |
| Normal | MH | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| I′drug/I′control | (n) | Delay [s] | (n) | I′drug/I′control | (n) | Delay [s] | (n) | |||
| DTNB (cis) | 5.28±1.47** | (10) | 68±13 | (13) | 3.91±0.92** | (9) | 198±38## | (14) | ||
| DTNB (trans) | 2.87±0.73** | (6) | 207±50 | (10) | 4.70±1.42** | (9) | 141±25 | (16) | ||
| DTDP (ethanol) | 6.56±3.34** | (12) | 138±48 | (15) | 4.22±1.53* | (7) | 214±35 | (8) | ||
| Ethanol (1%) | 2.65±1.03* | (5) | 168±21 | (8) | 1.79±0.51 | (6) | 150±13 | (5) | ||
| DTDP (H2O) | 3.41±1.64* | (8) | 100±15 | (18) | 3.02±0.87 | (13) | 156±27 | (13) | ||
| Relative changes in I′ (I′drug/I′control) are shown. DTNB and 4,4′-DTDP (DTDP) were added to a final concentration of 1mM. Data are given as mean±1 SEM.I′drug is significantly different from I′control with: *p<0.05. **p<0.01.I′drug/I′control for RyRMH is significantly different from I′drug/I′control for normal RyRs with: |
| ## p<0.01.DTDP (ethanol), DTDP dissolved in ethanol.DTDP (H2O), DTDP dissolved in cis solution. |
Channel activity with 1mM cis DTNB was not altered by subsequent addition of 2mM cis DTT (Results below) but returned toward control when 10mM DTT was added to the cis side of nine of nine RyRs activated by cis DTNB or to the trans side of three of three RyRs activated by trans DTNB (Figure 1 and Figure 2). This fall in activity was presumably due to reduction of -SH groups oxidized by DTNB, because DTT (10mM cis or trans) added without DTNB activated RyRs (Results below). The similar magnitude and time course of effects of cis or trans DTNB support the hypothesis that DTNB oxidizes -aSH, located in the transmembrane domain.
4,4′-DTDP (1mM cis added in ethanol, 1% v/v) caused an approximately sevenfold increase in I′, which began ∼2min after its addition to 15 of 15 channels (Table 1). In contrast to sheep cardiac (Eager et al) or rabbit skeletal (Ahern et al) RyRs, 1% ethanol (alone) increased I′ after ∼3min in eight of eight RyRs (Table 1). Therefore 4,4′-DTDP was dissolved in cis solution at 10mM and added to the cis chamber to a final concentration of ∼1mM. In this situation, I′ increased in 18 of 21 channels, after a delay of ∼1.5min (Table 1). Activity returned toward control after 2mM cis DTT addition to each of four single 4,4′-DTDP-activated RyRs (Figure 1BA and Figure 2BA). Thus 4,4′-DTDP also activated RyRs via oxidation of -SH groups, which could also be -aSH in the transmembrane domain.
Cis 4,4′-DTDP (1mM) abolished activity in seven of 10 RyRs, after 334±52s (4,4′-DTDP plus ethanol, Figure 2AIII), or in five of nine channels after 456±82s (4,4′-DTDP added in cis solution). Inactivated channels were not reactivated by four pulses to +40mV (0.03Hz). Infrequent activity remained in seven of 19 channels, for 26min in one case. RyRs were not inactivated after 5–30min with 1% ethanol alone (n=9). Cis DTT (2mM) restored activity after 129±62s in three of five RyRs inactivated by 4,4′-DTDP plus ethanol (Figure 2AIV) or after 240±165s in three of five RyRs inactivated by 4,4′-DTDP alone. Recovery with DTT shows that inactivation is due to -SH oxidation and that -iSH is present in skeletal RyRs and accessible to DTT. In contrast to 4,4′-DTDP, 1mM DTNB (either cis or trans) did not inactivate RyRs after 5–20min (Figure 2BIIIII). If activity fell, it increased again after pulses to +40mV.
The characteristics of normal RyRs and RyRMH (from homozygous MH pigs) were similar under control conditions at −40mV, with 100μM Ca2+ and symmetrical 250mM CsMS (Fig. 3). Single-channel conductance was 452±9 pS (n=4) for normal RyRs and 470±11 pS (n=5) for RyRMH, and control I′ for RyRMH was 1.76±0.13 pA (n=39), compared with ∼2.1 pA for 16 normal RyRs (Results above). In addition, both types of channel were 1) locked into a submaximum conductance state with 10–15μM cis ryanodine (RyR, n=11; RyRMH, n=12), 2) blocked by 5μM cis ruthenium red (RyR, n=3; RyRMH, n=2), and 3) activated by 5mM ATP (RyR, n=4; RyRMH, n=5).
Activity increased fourfold in 14 of 14 RyRMH channels ∼3min after the addition of 1mM cis DTNB or approximately fourfold in 16 of 17 channels ∼2min after trans DTNB (Fig. 3, Table 1). Activation of RyRMH by cis DTNB was significantly slower than activation of normal RyRs (p<0.01). There were no other differences in activation by DTNB between normal RyRs and RyRMH. 4,4′-DTDP added to RyRMH, with ethanol or alone (in cis solution), induced three- to fourfold increases in average I′ (Fig. 3), after 2.5–3.5min, while ethanol alone caused an approximately twofold increase in I′ after ∼2.5min (Table 1). RyRMH activity returned to control levels within 1min after 10mM DTT was added to the cis side of channels activated by cis DTNB (four of four) or trans DTNB (three of three) or after 2mM cis DTT was added to cis 4,4′-DTDP-activated channels (five of five). The similar results with normal RyRs and RyRMH show that the Arg615-to-Cys615 substitution in MH does not alter the ability of sulfhydryl-specific reagents to activate RyRs by oxidizing -aSH. The differences between RyRMH and normal RyRs in the rate of activation by cis DTNB could be explained by structural changes that reduce the accessibility of -aSH in RyRMH.
RyRMH channels were inactivated after 458±30s exposure to 1mM cis 4,4′-DTDP (added with 1% ethanol, n=10), and nine of the 10 channels were reactivated 160±30s after adding 2mM DTT. Similarly, 1mM cis 4,4′-DTDP added alone (in cis solution) abolished RyRMH activity in three of six channels after 383±156s, and the three channels recovered 50±26s after 2mM DTT was added. No RyRMH channels were inhibited during 3.5–32-min exposure to DTNB (cis or trans, n=13) or 4–30-min exposure to 1% cis ethanol (n=5). Thus inhibition of RyR channels via oxidation of -iSH was not altered by the MH mutation.
There were some curious exceptions to the general observations reported above. One normal and two RyRMH channels were inactivated 2–7min after 4,4′-DTDP was added, without initial activation, and inhibition was relieved 40–90s after cis DTT was added. This confirmed independent channel activation and inhibition and supported separate -aSH and -iSH residues (see also Eager and Dulhunty, 1998). Activity in three RyRMH and two normal RyRs fell after initial activation by cis 4,4′-DTDP, and activity in two normal RyRs fell 5min after cis 4,4′-DTDP was added, without any initial activation. There was no further change in activity in these seven channels when 2mM cis DTT was added, suggesting that the disulfide formed upon exposure to 4,4′-DTDP (-aS-Sr, where -Sr is contributed either by the reactive disulfide or by the channel protein) was reduced during exposure to 4,4′-DTDP and hence that the affinity of -aSH for 4,4′-DTDP in these channels was less than normal.
There was no significant difference between normal RyR (n=48) and RyRMH (n=45) in the steady-state parameter values for Po, Fo, To, and Tc measured over 30-s periods (Table 2). The two types of channel showed similar modes of activity, transitions between modes and responses to voltage pulses to +40mV (Fig. 4). Predominant modes were either low activity or high activity, unaltered after the voltage pulse (Figure 4III) or voltage-activated increase in activity immediately after the voltage pulse, which then decayed after 10–20s to a lower level that was also seen before the voltage pulse (Figure 4III). Strong submaximum conductance activity was also seen in both normal RyRs and RyRMH (Figure 4CD), giving an average open channel conductance that was 0.50±0.05 of the maximum conductance in normal RyRs or 0.37±0.09 in RyRMH.
| Table 2 Effects of oxidizing reagents and ethanol on single-channel parameters open probability (P0), mean open time (T0), mean closed time (Tc), and frequency of openings (F0) |
| Condition (n (normal, MH)) | P0 | T0 (ms) | Tc (ms) | F0 (s−1) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Normal | MH | Normal | MH | Normal | MH | Normal | MH | |||
| Control (8, 9) | 0.15±0.04 | 0.20±0.06 | 1.17±0.07 | 2.75±0.12 | 8.82±1.08 | 12.41±1.03 | 97±19 | 71±17 | ||
| DTNB (cis) | 0.27±0.05* | 0.41±0.06** | 5.26±0.81** | 6.68±0.22** | 11.22±1.22 | 11.19±1.24 | 62±21 | 64±10 | ||
| Control (6, 6) | 0.23±0.06 | 0.25±0.08 | 1.65±0.10 | 5.35±0.71 | 6.55±0.77 | 13.27±0.98 | 139±31 | 60±14 | ||
| DTNB (trans) | 0.48±0.12** | 0.56±0.09** | 4.72±0.72* | 11.46±1.17** | 5.74±0.97 | 8.39±0.82* | 125±34 | 64±16 | ||
| Control (6, 6) | 0.32±0.13 | 0.19±0.06 | 2.57±0.40 | 2.02±0.15 | 5.62±0.70 | 11.75±2.24 | 88±18 | 95±24 | ||
| DTDP (eth) | 0.67±0.13* | 0.38±0.11 | 13.23±3.35** | 5.85±0.78* | 5.83±1.58 | 10.17±1.55 | 74±24 | 73±18 | ||
| Control (4, 5) | 0.24±0.08 | 0.38±0.12 | 1.86±0.26 | 3.43±0.50 | 6.43±0.75 | 6.60±1.18 | 125±18 | 113±28 | ||
| Ethanol (1%) | 0.44±0.10* | 0.49±0.12 | 4.10±0.69* | 4.13±0.43* | 4.65±0.57 | 4.52±0.57 | 118±22 | 119±14 | ||
| Control (7, 5) | 0.17±0.06 | 0.20±0.07 | 1.20±0.19 | 1.05±0.57 | 7.65±1.26 | 4.15±1.81 | 72±17 | 78±31 | ||
| DTDP (H2O) | 0.42±0.11* | 0.40±0.09* | 8.32±2.37** | 2.59±1.06 | 9.84±2.78 | 6.87±8.50 | 50±17 | 86±26 | ||
| DTNB and 4,4′-DTDP (DTDP) were added to a final concentration of 1mM. Results are given as mean±1 SEM.Significant differences between parameters under control conditions and after addition of the reagent are indicated by: *p<0.05. **p<0.01.DTDP (ethanol), DTDP dissolved in ethanol.DTDP (H2O), DTDP dissolved in cis solution. |
The oxidizing reagents increased mean open time (To) in all normal RyRs and all RyRMH channels, with significant increases in average To under most conditions (Table 2). The effect on other aspects of channel activity was complex, with an increase in mean closed time (Tc) in some channels and a decrease in Tc in others, so that the changes in average Fo and Po were not significant (Table 2).
DTT at 10mM reversed the effects of DTNB, and at 2mM reversed the effects of 4,4′-DTDP in normal RyRs and RyRMH. Data were pooled from the few channels that were suitable for analysis and were exposed first to an oxidizing reagent and then to DTT. I′, Po, and To fell significantly after DTT was added to the oxidation-activated channels (Fig. 5). The similar actions of cis DTNB, trans DTNB, and cis 4,4′-DTDP on the single-channel parameters during activation and the similar reversal of these actions by DTT provide further evidence that one class of cysteine residues (-aSH) is oxidized in each of the three situations.
The average open channel conductance was higher after oxidation, being 0.50±0.05 of the maximum conductance before and 0.57±0.09 after oxidation in normal RyRs (n=25), or 0.37±0.05 before and 0.49±0.06 after in RyRMH (n=24, pooled data for cis DTNB, trans DTNB, and cis 4, 4′-DTDP), although the increase was significant only in RyRMH. This suggests that there was an increased fraction of openings to the maximum conductance and to higher submaximum conductance levels after oxidation-induced activation.
Open times for normal RyR and RyRMH fell into two exponential components under control conditions and three exponential components after oxidation-induced activation (Figure 6 and Figure 7). Closed times for both normal RyRs and RyRMH channels fell into three exponential components under control conditions and after oxidiation-induced activation. Data for normal RyRs and RyRMH were combined (Fig. 7) because there were no consistent differences in the average time constants or probability of events between the two channel types. Under control conditions and during oxidation-induced activation, the shortest open time constant, τo1, was ∼1–2ms, and the second time constant, τo2, was 7–13ms. The longest time constant, τo3, was seen only in “activated” channels; it was 50–100ms and contained <10% of openings. The increase in To was largely due to the appearance of τo3.
Closed time constants under control and oxidation-induced activation conditions were τc1 (2–4ms), τc2 (9–23ms), and τc3 (90–480ms) (Figure 6 and Figure 7). The longest component (τc3) contained very few events and did not change in any consistent way during oxidation-induced activation. The similar open and closed time distributions with cis DTNB, trans DTNB, and cis 4,4′-DTDP are consistent with the hypothesis that the same cysteine residues are oxidized with each reagent. An additional fourth long open time constant in cardiac RyRs exposed to cis 4,4′-DTDP (Eager and Dulhunty, 1999) was not seen in skeletal RyRs.
Channel openings in 20–50% of normal or RyRMH channels under control conditions was continuous, while activity in the other channels was clustered into bursts, separated by closures of 0.5–60s (not included in Figure 6 and Figure 7). Continuous or burst activity was observed in each of the three modes (high, low, or voltage-activated activity) defined in the text description of Figure 4I–III above. When either 1mM DTNB or 1mM 4,4′-DTDP was added to the cis chamber, 97% of channels adopted burst behavior, in addition to the increase in channel open time (Table 3). Only 59% of normal RyRs or RyRMH had burst behavior with trans DTNB-induced activation, or 45% during activation with cis or trans DTT (10mM, Results below) or with ethanol (Table 3). The stabilization of burst behavior by oxidizing reagents in the cis chamber was not reversed by DTT. Bursting behavior remained in 94% of channels when 10mM DTT was added to the cis or trans bath after 1mM cis DTNB, and remained in 50% of channels when 10mM DTT was added to the trans bath after 1mM trans DTNB.
| Table 3 Effects of oxidizing reagents and ethanol on burst behavior of normal RyRs and RyRMH |
| Before → After Continuous → Continuous | Before → After Continuous → Bursting | Before → After Bursting → Bursting | Before → After Bursting → Continuous | |||
|---|---|---|---|---|---|---|
| DTNB (cis) | ||||||
| Normal RyR | 0 | 8 | 10 | 0 | ||
| RyRMH | 0 | 2 | 16 | 0 | ||
| DTNB (trans) | ||||||
| Normal RyR | 8 | 0 | 4 | 1 | ||
| RyRMH | 3 | 0 | 15 | 1 | ||
| 4,4′-DTDP (eth) (cis) | ||||||
| Normal RyR | 0 | 6 | 9 | 1 | ||
| RyRMH | 0 | 1 | 13 | 0 | ||
| 4,4′-DTDP (H2O) (cis) | ||||||
| Normal RyR | 2 | 3 | 18 | 0 | ||
| RyRMH | 0 | 0 | 17 | 0 | ||
| Ethanol (1%) (cis) | ||||||
| Normal RyR | 1 | 1 | 7 | 1 | ||
| RyRMH | 0 | 1 | 13 | 1 | ||
| Oxidizing reagents were added to a final concentration of 1mM. The numbers of channels are shown with continuous or bursting activity before and after addition of the agents listed on the left-hand side, for normal RyRs and RyRMH.4,4′-DTDP (eth), 4,4′-DTDP dissolved in ethanol.4,4′-DTDP (H2O), 4,4′-DTDP dissolved in cis solution. |
This effect of oxidizing reagents on burst activity suggested that DTNB and 4,4′-DTDP modified a site on the cytoplasmic side of the channel that alters channel gating to stabilize bursting behavior. It is unclear whether the effect is due to -SH oxidation or an interaction between the oxidizing reagents and other sites on the channel, because the effect was not reversed by DTT.
If the hypothesis that -aSH is located in the transmembrane domain and is accessible from either side of the bilayer is correct, then activation by DTNB on one side of the bilayer should be reversed by adding DTT to the opposite chamber. In this experiment, five of six RyR channels were activated when DTNB was added to the cis chamber, and activity fell in five of the channels when DTT was added to the trans chamber. Conversely, one of three other channels was activated when DTNB was added to the trans chamber, and activity fell in that channel when DTT was added to the cis chamber.
DTT at 2mM, added in the absence of an oxidizing reagent, did not significantly alter RyR activity. The mean current, normalized to control, was 3.6±2.8 in five normal RyRs after 2mM DTT addition and 2.7±0.4 in five RyRMH channels. On the other hand, 10mM DTT significantly activated normal RyRs and RyRMH when added to either the cis or trans chamber in the absence of added oxidizing reagent; activity then fell toward control levels when 1mM DTNB was added to the opposite side of the bilayer (Fig. 8). Cis DTT (10mM) activated five of five RyRs (two normal; three RyRMH), while trans DTT activated two of four normal RyRs and three of three RyRMH. Data from normal RyRs and RyRMH is combined in Fig. 8. The two RyRs not activated by trans DTT were not included, because their control activity was high (I′ of 4.0 and 6.8 pA) and outside the range of 0.2–1.2 pA in the other five channels. Average I′ increased significantly with 10mM DTT (cis or trans) and then fell significantly after DTNB addition to the opposite chamber (Fig. 9). Interestingly, activity in the two channels that were not activated by cis DTT fell to lower levels when DTNB was added to the trans chamber, with similar approximately sixfold reductions in I′. These channels may have already been in a reduced state before the addition of DTT.
These results suggest that a class of modified thiol (-abS-R-, where R is either a protein S if the modified thiol is a disulfide, or a N if the modified group is nitrosylated; Xu et al) is available to 10mM DTT from either the cis or trans chamber and that the reduced -abSH can be oxidized by DTNB from the opposite side of the bilayer. The accessibility from either side of the bilayer indicates that -abS-R- and -abSH are located in the transmembrane domain.
Channel activity returned to “control-like” levels when 10mM DTT and 1mM DTNB were present on either the same or opposite sides of the bilayer. This was confirmed in further experiments, in which the “control-like” activity was maintained if 10mM DTT was present on both sides of the channel, with 1mM DTNB on one side only (five of six experiments with cis DTNB, or three of three with trans DTNB). Average I′ measured in four of the channels with cis DTNB or two of the channels with trans DTNB was −2.19±0.32 pA. “Control-like” activity was retained when 10mM DTT was removed from one chamber, leaving 10mM DTT and 1mM DTNB in the cis chamber in two cases, or in the trans chamber in a third case (I′=−1.33±0.51 pA).
The assertion that channel activity in the presence of 10mM DTT and 1mM DTNB was “control-like” was supported by a final experiment (n=2) in which the trans chamber initially contained 1mM DTNB plus 10mM DTT and the cis chamber contained 1mM DTNB (I′=−0.97±0.39 pA). The trans chamber was perfused with normal trans solution, leaving 1mM DTNB in the cis solution. In both cases, RyR activity increased after perfusion, as it usually did when DTNB was present alone in the cis chamber (I′=−5.50±0.33 pA).
We found that DTNB activated skeletal muscle RyRs from either the cytoplasmic or luminal side of the channel, while 4,4′-DTDP activated and then inhibited RyRs from the cytoplasmic solution. Activation by both reagents and inhibition by 4,4′-DTDP were reversed by DTT and thus are due to sulfhydryl oxidation. The results can be explained by oxidation of two classes of sulfhydryl, -aSH in the transmembrane domain for activation or -iSH in a hydrophobic environment for inhibition. Separate -aSH and -iSH residues have also been postulated for cardiac RyRs (Eager and Dulhunty, 1998,Eager and Dulhunty, 1999). Additional novel findings were that 1) addition of the oxidizing reagents to the cis side of RyRs stabilized bursting channel activity, suggesting that cytoplasmic residues regulate burst activity; 2) addition of 10mM DTT to either side of the channel caused activation, which was reversed when DTNB was added to the opposite side, suggesting that a modified thiol -abS-R- in the transmembrane domain normally inhibits activity; and 3) “control-like” channel activity was maintained in the presence of 1mM DTNB and 10mM DTT. Finally, the effects of the oxidizing reagents on RyRs from normal and MH pigs were similar.
Activation of skeletal RyRs by DTNB and 4,4′-DTDP confirms previous reports on skeletal RyRs (Nagura et al,Marengo et al,Zable et al). Similar activation, with a long time constant component introduced into the open time distribution, is seen in cardiac RyRs exposed to 4,4′-DTDP or thimerosal. An increase in open frequency is also seen in cardiac RyRs. A fourth long time constant component in the open time distribution of cardiac RyRs oxidized by 4,4′-DTDP was not seen in skeletal RyRs, suggesting that the -a*SH class of sulfhydryl, postulated for the cardiac RyR (Eager and Dulhunty, 1998), either is not present or is not available for oxidation in skeletal RyRs. The fact that reversal of activation by 1mM DTNB required 10mM DTT, while reversal of activation by 4,4′-DTDP or thimerosal requires 2mM DTT (results above and Eager and Dulhunty, 1999), suggests that DTNB has stronger oxidative properties than 4,4′-DTDP. The failure of GSSG to activate skeletal RyRs from the luminal solution (Zable et al) might have been due to the weak oxidizing ability of GSSG.
The ability of DTNB to activate RyRs from the luminal or cytoplasmic side and the reversal of activation by 10mM DTT added to the opposite side of the channel suggest that -aSH is accessible to DTNB and DTT from the cytoplasmic and luminal solutions. This accessibility to water-soluble reagents could suggest that target residues are located in the channel pore. However, DTT with a pKa of 9.0–10 (Shaked et al) would be largely uncharged at pH 7.4 and would rapidly partition into the membrane. Similarly, 1–10% of DTNB with a pKa of 5–6 (Houk et al) would enter the membrane. Thus the water-soluble agents could access residues located in the transmembrane domain, not in the pore, although activating residues in a transmembrane, rather than pore location, would see only 10–100μM DTNB. This is not an unreasonable [DTNB] for activation, because DTNB is a strong oxidizing reagent (above), and NO at ∼40 nM nitrosylates thiol groups and activates skeletal RyRs (Hart and Dulhunty, unpublished observations), while cardiac RyRs are activated by 100μM 4,4′-DTDP (Eager et al).
It is unlikely that the reagents, either crossing the membrane or passing through the pore, could have targeted residues located on the opposite side of the channel and remote from the membrane, because dilution in the large volume of solution would mean that it would take a long time for their concentrations to increase to active levels. Thus activation with DTNB or recovery with DTT would have been faster when the reagents were applied to the side of the channel containing the residues. Because similar rates of activation and deactivation were seen with cis and trans applications of both reagents, we conclude that DTNB and DTT act at a transmembrane (possibly pore) location.
Another possibility is that separate actions of DTNB on cytoplasmic and luminal sulfhydryls result in similar functional effects on RyR activity (Eager and Dulhunty, 1998). However, reversal of activation by DTT on the opposite side of the bilayer would not be expected if -aSH were distributed over the luminal and cytoplasmic domains of the RyR. If -aSH is located in the channel pore, then DTT, DTNB, and 4,4′-DTDP must penetrate the channel. Molecules of a mass similar to that of DTT (formula weight, FW 154) and 4,4′-DTDP (FW 220), such as glucose and xylose (FW 180 and 150, respectively), pass slowly through skeletal RyRs (Meissner, 1986,Kasai et al). DTNB (FW 396) and thimerosal (FW 405) have a greater mass but may nevertheless assume conformations that allow them to also pass through the channel. Curiously, neither DTNB nor 4,4′-DTDP nor DTT blocks the channel into the low-conductance states seen in the presence of the smaller (FW 110–172) methanethiosulfonate (MTS) derivatives (Quinn and Ehrlich, 1997). Although DTNB and 4,4′-DTDP are cleaved during oxidation of protein thiols, their half-masses of 110 and 198 remain equivalent to that of the MTS compounds. If DTT, DTNB, and 4,4′-DTDP enter the pore and interact with sulfhydryl residues to alter channel gating, they must do so without physically blocking the pore.
We propose that oxidation of separate -aSH and -iSH leads, respectively, to activation and inhibition of RyRs, rather than oxidation of one class of sulfhydryl that first activates and then inhibits the channel. Evidence for separate residues is that 1) activation by DTNB was not followed by inhibition and 2) inhibition was observed without preceding activation in some channels (see also Eager et al). RyR inhibition by 4,4′-DTDP, but not DTNB, suggested that -iSH may be located in a domain of the skeletal RyR that is inaccessible to DTNB. In contrast, the water-soluble thimerosal inhibited cardiac RyRs (Eager and Dulhunty, 1999). This apparent difference may have been due to the use of thimerosal in cardiac and DTNB in skeletal RyRs, because thimerosal penetrates proteins more effectively than other thiol reagents (van Iwaarden et al).
An alternative possibility is that the different abilities of DTNB, 4,4′-DTDP, and thimerosal to inhibit RyRs are related to their different redox potentials. Sulfhydryl-specific oxidizing reagents can react with proteins in two steps (Glazer, 1970). The first step is the formation of a mixed disulfide between the protein thiol (-aSH, for example) and the reagent (rS-Sr):
![]() |
![]() |
It is possible that the same cysteine residues form -aSH in cardiac and skeletal RyRs. Many cysteine residues in the channel domain are conserved between cardiac and skeletal RyRs (Otsu et al) and are in an appropriate location for -aSH. The subtly different effects of oxidation on the gating of the cardiac and skeletal RyRs could be attributed to a difference in the connections between the -aSH and the channel gating mechanisms. Such a difference may be imposed by sequence differences between the cardiac and skeletal RyRs (having only 66% sequence identity; Otsu et al), which could impose structural differences between the proteins.
Skeletal RyR channels recovered from inhibition when DTT was added to the cis solution, but the loss of activity in cardiac RyRs could not be reversed by DTT (Eager et al). Inhibition of skeletal RyRs by NO is also relieved by DTT (Hart and Dulhunty, unpublished observations). These observations suggest that the oxidized xS-Si- (where -xS is contributed either by DTNB or 4,4′-DTDP or by the protein) is more accessible to DTT in skeletal RyRs than in cardiac RyRs.
Addition of 10mM DTT to either side of the bilayer (with oxidizing reagents absent from cis and trans solutions) increased RyR activity. Increased mammalian skeletal RyR activity with DTT is in contrast to a fall in Po when 20mM GSH was added to frog skeletal or rabbit cardiac RyRs (Marengo et al) or when 10mM DTT was added to sheep cardiac RyRs (Eager et al). Zable et al also showed a reduction in rabbit skeletal RyR activity with 6–10mM GSH and reduced ryanodine binding with GSH, DTT, and BME. The reason for the difference between our results and those of Zable et al. may be partly due to sequence differences between pig and rabbit RyRs (see below). However, we also find that rabbit skeletal RyR activity increases when 2mM DTT alone is added to the trans chamber (Green, Hart, and Dulhunty, unpublished observations). In agreement with our findings, DTT induces contraction in intact frog skeletal muscle fibres by triggering Ca2+ release from SR (Oba et al).
Activation of skeletal RyRs by cis or trans DTT and its reversal with DTNB in the opposite chamber suggest that a class of modified thiols, -abS-R-, which normally suppresses channel activity, is present in the mammalian skeletal RyR transmembrane region. The R group could be contributed either by another protein cysteine if a disulfide is formed or could be a N if -abS is nitrosylated. Cardiac RyRs contain stable nitrosothiols if isolated in the absence of DTT, and nitrosylated thiols can be denitrosylated by 10mM DTT (Xu et al). The pig SR used in the present experiments was isolated in the presence of 2mM DTT, which may not have denitrosylated all nitrosothiols on the RyRs. Denitrosylation, however, is difficult to reconcile with the reversibility of the effects of DTT by DTNB, unless it is also suggested that modification per se depresses channel activity, independent of whether the thiol is nitrosylated or oxidized by DTNB. It seems more likely that the modified thiol is part of an intraprotein disulfide bridge.
Two cysteine residues in the skeletal RyR, one just outside the M1 region and one between M5 and M6, are not present in cardiac RyRs (Otsu et al). These cysteines are likely to be in the transmembrane region and could form disulfide bridges or be available for S-nitrosylation.
The observation that channel activity returned to “control-like” levels when 1mM DTNB and 10mM DTT were present, either on the same or opposite sides of the bilayer, provided further evidence that -aSH and -abS-R- are located in the transmembrane domain. The fact that removal of DTT, leaving only DTNB in one chamber, resulted in channel activation, which was similar to that seen when DTNB was added alone, supported the suggestion that channel activity was “control-like” when the two reagents were present together. The result suggests that redox cycling with 1mM DTNB plus 10mM DTT kept -abS-R- mostly in its modified form, and -aSH mostly in its reduced form.
Activation of normal RyRs and RyRMH by 1% ethanol after 2–3min was unexpected because exposure to ethanol for the same period does not alter single-channel activity of cardiac (Eager et al) or rabbit skeletal (Ahern et al) RyRs. However, open times increase if rabbit skeletal RyRs are exposed to ethanol for 5min (Dulhunty and Curtis, unpublished observations). The results may reflect intrinsic differences between pig and rabbit skeletal RyRs reported previously. The maximum rate of polylysine-induced Ca2+ release is four times greater in pig skeletal SR than that in rabbit SR (El-Hayek et al,Cifuentes et al). In addition, pig RyRs are less sensitive than rabbit RyRs to activation by peptides corresponding to the loop between membrane-spanning segments II and III of the skeletal DHPR (Gallant, Pace, and Dulhunty, 1999). These functional differences are likely to be imposed by sequence differences between the pig and rabbit RyRs. There are 45 residues (two cysteines) that differ between the pig and rabbit RyRs in the first 1500 residues of the protein, with an overall 3% dissimilarity (Fujii et al).
RyRMH responded to oxidation and reduction in a way similar to that of normal RyRs. Therefore the additional cysteine residue in MH does not alter the response of the RyR to either oxidizing or reducing reagents. Either Cis615 is buried in the protein and is not accessible to the redox reagents, or oxidation/reduction of the additional -SH or -S-R- does not effect channel activity under the conditions of our experiments. The response of RyRs to oxidation can depend on ligands bound to the protein (Eager and Dulhunty, 1998; Xu et al); thus it remains possible that Cis615 in RyRMH becomes available for oxidation or reduction, or that the modified residue is able to regulate activity, during increased Ca2+ release and increased metabolic activity, and can thus further enhance Ca2+ release from the SR during the MH response.
In conclusion, the similar effects of oxidizing reagents in cardiac and skeletal RyRs suggest that at least two of the cysteine residues whose modification alter channel gating are conserved between the two proteins. The results further suggest that free -SH residues and modified thiols are present in the transmembrane region of the skeletal RyR under control conditions and that their covalent modification under oxidizing or reducing conditions can significantly modify RyR channel gating.
The authors are grateful to Suzi Pace and Joan Stivala for their assistance in the preparation of SR vesicles from normal and MH pigs. The isolation of the vesicles, caffeine/halthane testing, and genetic testing were done in collaboration with Drs. Virginia Owen, Pauline Junankar, Derek Laver, Graham Lamb, Nicole Taske, and Paul Foster (Laver et al).
Abramson et al., 1995 (1995). Thimerosal interacts with the Ca2+ release channel ryanodine receptor from skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 270, 29644–29647. CrossRef | PubMed
Ahern et al., 1994 (1994). Single channel activity of the ryanodine receptor calcium release channel is modulated by FK506. FEBS Lett. 352, 369–374. CrossRef | PubMed
Ahern et al., 1997a (1997). Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. Biophys. J. 72, 146–162. Abstract | | CrossRef | PubMed
Ahern et al., 1997b (1997). Ryanodine receptors from rabbit skeletal muscle are reversibly activated by rapamycin. Neurosci. Lett. 225, 81–84. CrossRef | PubMed
Boraso and Williams, 1994 (1994). Modification of the gating of the cardiac sarcoplasmic reticulum Ca++-release channel by H2O2 and dithiothreitol. Am. J. Physiol. 267, H1010–H1016. PubMed
Carrier et al., 1991 (1991). Abnormal rapid Ca++ release from sarcoplasmic reticulum of malignant hyperthermia susceptible pigs. Biochim. Biophys. Acta 1064, 175–183. PubMed
Cifuentes et al., 1989 (1989). Polylysine induces a rapid Ca2+ release from sarcoplasmic reticulum vesicles by mediation of its binding to the foot protein. Arch. Biochem. Biophys. 273, 554–561. CrossRef | PubMed
Curello et al., 1985 (1985). Changes in the cardiac glutathione status after ischemia and reperfusion. Experientia 41, 42–43. CrossRef | PubMed
Eager and Dulhunty, 1998 (1998). Activation of the cardiac ryanodine receptor by sulfhydryl oxidation is modified by Mg2+ and ATP. J. Membr. Biol. 163, 9–18. CrossRef | PubMed
Eager and Dulhunty, 1999 (1999). Cardiac ryanodine receptor activity is altered by oxidising reagents in either the luminal or cytoplasmic solution. J. Membr. Biol. 167, 205–214. CrossRef | PubMed
Eager et al., 1997 (1997). Actions of sulfhydryl reagents on single ryanodine receptor calcium release channels from sheep myocardium. Am. J. Physiol. 272, 1908–1919. PubMed
El-Hayek et al., 1995 (1995). Altered E-C coupling in triads isolated from malignant hyperthermia-susceptible porcine muscle. Am. J. Physiol. 268, C1381–C1386. PubMed
Favero et al., 1995 (1995). Hydrogen peroxide stimulates the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 270, 25557–25563. CrossRef | PubMed
Fill et al., 1991 (1991). Abnormal human sarcoplasmic reticulum Ca++ release channels in malignant hyperthermic skeletal muscle. Biophys. J. 59, 1085–1090. Abstract | | CrossRef | PubMed
Fujii et al., 1991 (1991). Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253, 448–451. PubMed
Glazer, 1970 (1970). Specific chemical modification of proteins. Annu. Rev. Biochem. 39, 101–130. PubMed
Holmberg et al., 1991 (1991). Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel.